A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients
Clinical trial NCT02625636 · COMPLETED
Trial details
- NCT number
- NCT02625636
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.